Neuroendocrine profile of the potential anxiolytic drug S-20499

By Levy A.D.   Li Q.   Gustafson M.   Van de Kar L.D.  

European Journal of Pharmacology, Vol. 274, Iss. 1, 1995-02 ,pp. : 141-149

Elsevier

Access to resources Recommend Favorite

Antidepressant-like effects of alnespirone (S 20499) in the learned helplessness test in rats

By Mac Sweeney C.P.   Lesourd M.   Gandon J.-M.  

European Journal of Pharmacology, Vol. 345, Iss. 2, 1998-03 ,pp. : 133-137

Elsevier

Access to resources Recommend Favorite

An investigation of the antidepressant properties of lofepramine and its desmethylated metabolites in the forced swim and olfactory bulbectomized rat models of depression

By Kelly J.P.   Leonard B.E.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 101-105

Elsevier

Access to resources Recommend Favorite

Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat

By Connor T.J.   Kelliher P.   Harkin A.   Kelly J.P.   Leonard B.E.  

European Journal of Pharmacology, Vol. 379, Iss. 2, 1999-08 ,pp. : 125-133

Elsevier

Access to resources Recommend Favorite

Is the potent 5-HT 1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain?

By Dugast C.   Souliere F.   Schmitt P.   Casanovas J.M.   Fattaccini C.-M.   Mocaer E.   Lesourd M.   Renaud B.   Artigas F.   Hamon M.   Chouvet G.  

European Journal of Pharmacology, Vol. 350, Iss. 2, 1998-06 ,pp. : 171-180

Elsevier

Access to resources Recommend Favorite